Sonia del Barco Berrón

Suggest Changes
Learn More
PURPOSE Capecitabine is an active drug in metastatic breast cancer (BC). GEICAM/2003-10 is an adjuvant trial to investigate the integration of capecitabine into a regimen of epirubicin and docetaxel(More)
  • 1